Valuation: Neuland Laboratories Limited

Market Cap 261B 2.78B 2.49B 2.3B 2.09B 3.95B 4.06B 27.52B 10.96B 140B 10.44B 10.22B 442B P/E 2027 *
59.7x
P/E 2028 * 44.4x
Enterprise Value 263B 2.81B 2.52B 2.32B 2.11B 3.99B 4.1B 27.78B 11.07B 141B 10.54B 10.31B 446B EV / Sales 2027 *
11.3x
EV / Sales 2028 * 9.15x
Free-Float
62.26%
Yield 2027 *
0.17%
Yield 2028 * 0.14%
1 day-0.58%
1 week+3.01%
Current month+2.56%
1 month-1.80%
3 months-11.97%
6 months+15.14%
Current year+33.01%
1 week 19,055.55
Extreme 19055.55
20,990
1 month 18,123.75
Extreme 18123.75
21,230
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 4,928
Extreme 4928
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%+3.01%+17.46%+277.88% 2.78B
-0.74%+1.63%+48.17%+139.63% 1,276B
-1.24%+5.49%+49.03%+90.68% 676B
-0.71%+2.76%+34.37%+112.06% 519B
-0.32%+1.01%+38.52%+67.50% 388B
-1.22%+2.34%+70.66%+46.02% 365B
-1.00%-1.03%+27.67%+57.03% 307B
+0.01%-1.00%+3.10%+35.48% 287B
-0.95%+0.86%+43.74%+74.04% 252B
-0.44%+2.03%+44.62%+125.07% 212B
Average -0.70%+2.49%+37.73%+102.54% 429B
Weighted average by Cap. -0.76%+2.51%+42.73%+96.68%

Financials

2027 *2028 *
Net sales 23.37B 249M 224M 206M 187M 354M 364M 2.47B 983M 12.52B 935M 915M 39.58B 28.6B 305M 274M 252M 229M 433M 445M 3.02B 1.2B 15.32B 1.14B 1.12B 48.44B
Net income 4.38B 46.76M 41.94M 38.65M 35.1M 66.43M 68.28M 463M 184M 2.35B 175M 172M 7.43B 5.9B 62.91M 56.41M 51.99M 47.22M 89.36M 91.86M 623M 248M 3.16B 236M 231M 9.99B
Net Debt 2.49B 26.56M 23.82M 21.95M 19.94M 37.73M 38.79M 263M 105M 1.33B 99.69M 97.57M 4.22B 1.08B 11.53M 10.34M 9.53M 8.65M 16.37M 16.83M 114M 45.44M 579M 43.25M 42.34M 1.83B
Projected Income Statement - Annual - Neuland Laboratories Limited
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
11/11/26 ₹20,204.85 -0.58% 4,357
09/11/26 ₹20,323.05 +2.25% 3,066
08/11/26 ₹19,876.80 +0.91% 651
06/11/26 ₹19,696.75 -0.38% 1,763
05/11/26 ₹19,771.85 +0.80% 3,767
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Neuland Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
20,323.05INR
Average target price
24,675.00INR
Spread / Average Target
+21.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Neuland Laboratories Limited
  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock